References
- Bubeck B., Brandau W., Steinbächer M., et al. Technetium- 99m labeled renal function and imaging agents. II. Clinical evaluation of 99mTc MAG3 (99m mercaptoacetylglycylglycylglycine.). Nucl. Med. Biol 1988; 15: 109
- Fritzberg A. R., Kasina S., Eshima D., Johnson D. L. Synthesis and biologic evaluation of technetium-99m MAG3 as a hippuran replacement. J. Nucl. Med 1986; 27: 111
- Jafri A. R., Britton K. E., Nimmon C. C., et al. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J. Nucl. Med 1988; 29: 147
- O'Reilly P. H., Testa H. J., Lawson R. S., Farrar P. J., Edwards E. Charlton. Diuresis renography in equivocal urinary tract obstruction. Brit. J. Urol 1978; 50: 76
- Russel C. D., Thorstad B., Yester M. V., et al. Comparison of Tc-99m-MAG3 with I-131 hippuran by a simultaneous dual channel technique. J. Nucl. Med 1988; 29: 1189
- Taylor A., Jr, Eshima D. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, Iodine OIH, and Iodine-125 Iothalamate. J. Nucl. Med 1988; 29: 669
- Taylor A., Jr, Eshima D., Alazraki N. 99mTc-MAG3, a new renal imaging agent. Preliminary results in patients. Eur. J. Nucl. Med 1987; 12: 510
- Taylor A., Jr, Eshima D., Christian P. E., Milton W. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function. Radiology 1987; 162: 365
- Taylor A., Jr, Eshima D., Christian P. E., Wooten W. W., Hansen L., McElvany K. Technetium-99m MAG3 kit formulation. Preliminary results in normal volunteers and patients with renal failure. J. Nucl. Med 1988; 29: 616
- Taylor A., Jr, Eshima D., Fritzberg A. R., Christian P. E., Kasina S. Comparison of I-131-OIH and technetium-99m-MAG3 renal imaging in volunteers. J. Nucl. Med 1986; 27: 795
- Whitaker R. J. Methods of assessing obstruction in dilated ureters. Brit. J. Urol 1973; 45: 15